PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Krieckaert, Charlotte
TI  - Concomitant DMARD Therapies Increase Adalimumab Serum Concentrations in Patients with Rheumatic Diseases
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 23--23
VI  - 14
IP  - 17
4099  - http://mdc.sagepub.com/content/14/17/23.short
4100  - http://mdc.sagepub.com/content/14/17/23.full
AB  - Patients with rheumatoid arthritis (RA) who are treated with adalimumab plus methotrexate (MTX) have higher serum trough levels of adalimumab and a better clinical response to therapy than patients treated with adalimumab alone [Pouw MF et al. Ann Rheum Dis 2013]. This article discusses the effect on adalimumab serum concentrations in patients with RA or psoriatic arthritis taking concomitant MTX and concomitant disease-modifying antirheumatic drugs (DMARDs) other than MTX.